MYGN MYRIAD GENETICS INC
Nasdaq · SEC CIK 899923 · EDGAR
- Bought, last 12 months
- $722.2K 3 purchases by 3 insiders
- Sold, last 12 months
- $66.8K 1 sales by 1 insiders
- Filings on record
- 310 since 2021-07-08, latest 2026-09-22 16:12
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Phanstiel S. Louise | Dir | $494.5K | — |
| Raha Samraat S. | Pres, CEO, Dir | $200.0K | — |
| Kumar Rashmi | Dir | — | $66.8K |
| Bisaro Paul | Dir | $27.6K | — |
| Jampa Raj | CTO | — | — |
| Wheeler Benjamin Richard | CFO | — | — |
| Donnelly Brian J | Chief Commerical Off | — | — |
| Davis Mark Steven | Dir | — | — |
| Sikri Vishal | EVP, Commercial | — | — |
| Muzzey Dale | CSO | — | — |
Transactions 344
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-12 | 2021-10-09 | MYGN | Haas Kevin Richard | CTO | F - Tax | $30.88 | -1,729 | 53.2K | -3% | -$53.4K | |
| 2021-10-04 | 2021-10-01 | MYGN | Lambert Nicole | See Remarks | S - Sale | $31.57 | -1,420 | 176.7K | -0.8% | -$44.8K | |
| M | 2021-09-27 | 2021-09-25+ | MYGN | Hart Jayne B. | CHRO | F - Tax | $33.31 | -6,094 | 110.1K | -5% | -$203.0K |
| M | 2021-09-27 | 2021-09-25+ | MYGN | Haas Kevin Richard | CTO | F - Tax | $33.31 | -1,211 | 55.8K | -2% | -$40.3K |
| M | 2021-09-27 | 2021-09-25+ | MYGN | Lambert Nicole | See Remarks | F - Tax | $33.31 | -4,737 | 188.2K | -2% | -$157.8K |
| 2021-09-27 | 2021-09-27 | MYGN | Lambert Nicole | See Remarks | S - Sale | $33.10 | -10.1K | 178.1K | -5% | -$334.7K | |
| 2021-09-27 | 2021-09-23 | MYGN | LANCHBURY JERRY S | CSO | S - Sale | $35.06 | -200 | 288.5K | -0.1% | -$7,012 | |
| M | 2021-09-27 | 2021-09-25+ | MYGN | LANCHBURY JERRY S | CSO | F - Tax | $33.31 | -13.4K | 278.8K | -5% | -$445.7K |
| 2021-09-27 | 2021-09-23 | MYGN | DIAZ PAUL J | Pres, CEO, Dir | F - Tax | $34.76 | -49.4K | 796.1K | -6% | -$1.72M | |
| 2021-09-27 | 2021-09-23 | MYGN | DIAZ PAUL J | Pres, CEO, Dir | A - Grant | $0.00 | +445.4K | 845.5K | +111% | $0 | |
| M | 2021-09-27 | 2021-09-25+ | MYGN | Riggsbee Richard Bryan | CFO | F - Tax | $33.31 | -16.4K | 373.7K | -4% | -$547.9K |
| M | 2021-09-27 | 2021-09-25+ | MYGN | Verratti Mark | Pres, Myriad Neuroscience | F - Tax | $33.31 | -10.3K | 205.9K | -5% | -$341.8K |
| 2021-09-23 | 2021-09-21 | MYGN | Riggsbee Richard Bryan | CFO | A - Grant | $0.00 | +67.0K | 385.6K | +21% | $0 | |
| 2021-09-23 | 2021-09-21 | MYGN | Lambert Nicole | See Remarks | A - Grant | $0.00 | +65.9K | 192.9K | +52% | $0 | |
| 2021-09-23 | 2021-09-21 | MYGN | LANCHBURY JERRY S | CSO | A - Grant | $0.00 | +58.4K | 288.7K | +25% | $0 | |
| 2021-09-23 | 2021-09-21 | MYGN | Hart Jayne B. | CHRO | A - Grant | $0.00 | +26.6K | 116.2K | +30% | $0 | |
| M | 2021-09-23 | 2021-09-21 | MYGN | Verratti Mark | Pres, Myriad Neuroscience | A - Grant | $0.00 | +56.6K | 212.6K | +36% | $0 |
| DM | 2021-09-21 | 2021-09-17 | MYGN | Hart Jayne B. | CHRO | M - OptEx | $26.49 | +77.0K | 92.6K | +494% | +$2.04M |
| DM | 2021-09-21 | 2021-09-17 | MYGN | Hart Jayne B. | CHRO | S - Sale+OE | $33.72 | -67.4K | 88.8K | -43% | -$2.27M |
| 2021-08-30 | 2021-08-27 | MYGN | Lambert Nicole | See Remarks | S - Sale | $34.50 | -945 | 127.1K | -0.7% | -$32.6K | |
| 2021-08-26 | 2021-08-25 | MYGN | Riggsbee Richard Bryan | CFO | F - Tax | $34.81 | -3,058 | 318.6K | -1.0% | -$106.4K | |
| 2021-08-26 | 2021-08-10 | MYGN | Riggsbee Richard Bryan | CFO | G - Gift | $0.00 | -3,250 | 321.7K | -1% | $0 | |
| 2021-08-26 | 2021-08-25 | MYGN | Hart Jayne B. | CHRO | F - Tax | $34.81 | -1,148 | 80.1K | -1% | -$40.0K | |
| 2021-08-26 | 2021-08-25 | MYGN | LANCHBURY JERRY S | CSO | F - Tax | $34.81 | -2,233 | 230.3K | -1.0% | -$77.7K | |
| 2021-08-26 | 2021-08-25 | MYGN | Lambert Nicole | See Remarks | F - Tax | $34.81 | -1,123 | 128.0K | -0.9% | -$39.1K | |
| 2021-08-26 | 2021-08-25 | MYGN | Verratti Mark | Pres, Myriad Neuroscience | F - Tax | $34.81 | -1,082 | 156.0K | -0.7% | -$37.7K | |
| DM | 2021-08-25 | 2021-08-23+ | MYGN | LANCHBURY JERRY S | CSO | S - Sale+OE | $35.32 | -80.0K | 232.6K | -26% | -$2.83M |
| DM | 2021-08-25 | 2021-08-23+ | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $27.07 | +80.0K | 262.6K | +44% | +$2.17M |
| 2021-08-16 | 2021-08-13 | MYGN | DIAZ PAUL J | Pres, CEO, Dir | F - Tax | $32.79 | -58.8K | 400.0K | -13% | -$1.93M | |
| DM | 2021-08-06 | 2021-08-05 | MYGN | Phanstiel S. Louise | Dir | M - OptEx | $23.34 | +60.0K | 91.6K | +190% | +$1.40M |
| D | 2021-08-06 | 2021-08-05 | MYGN | Phanstiel S. Louise | Dir | S - Sale+OE | $35.04 | -47.9K | 61.6K | -44% | -$1.68M |
| D | 2021-08-06 | 2021-08-05 | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $27.07 | +28.2K | 260.8K | +12% | +$764.1K |
| D | 2021-08-06 | 2021-08-05 | MYGN | LANCHBURY JERRY S | CSO | S - Sale+OE | $35.57 | -28.2K | 232.6K | -11% | -$1.00M |
| DM | 2021-08-05 | 2021-08-03+ | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $25.99 | +100.0K | 260.4K | +62% | +$2.60M |
| DM | 2021-08-05 | 2021-08-03+ | MYGN | LANCHBURY JERRY S | CSO | S - Sale+OE | $34.68 | -100.0K | 232.6K | -30% | -$3.47M |
| 2021-08-05 | 2021-08-03 | MYGN | Riggsbee Richard Bryan | CFO | S - Sale | $35.14 | -15.0K | 324.9K | -4% | -$526.5K | |
| D | 2021-08-05 | 2021-08-03 | MYGN | LANGER DENNIS | Dir | S - Sale+OE | $34.75 | -30.0K | 89.5K | -25% | -$1.04M |
| D | 2021-08-05 | 2021-08-03 | MYGN | LANGER DENNIS | Dir | M - OptEx | $25.39 | +30.0K | 119.5K | +34% | +$761.7K |
| DM | 2021-07-14 | 2021-07-12+ | MYGN | LANCHBURY JERRY S | CSO | S - Sale+OE | $33.64 | -93.3K | 232.6K | -29% | -$3.14M |
| DM | 2021-07-14 | 2021-07-12+ | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $26.49 | +93.3K | 272.6K | +52% | +$2.47M |
| DM | 2021-07-12 | 2021-07-09 | MYGN | LANCHBURY JERRY S | CSO | S - Sale+OE | $32.62 | -50.0K | 232.6K | -18% | -$1.63M |
| DM | 2021-07-12 | 2021-07-09 | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $24.01 | +50.0K | 259.3K | +24% | +$1.20M |
| DM | 2021-07-08 | 2021-07-07 | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $26.49 | +32.3K | 234.4K | +16% | +$855.8K |
| DM | 2021-07-08 | 2021-07-07 | MYGN | LANCHBURY JERRY S | CSO | S - Sale+OE | $32.27 | -32.3K | 232.6K | -12% | -$1.04M |
Purchase Sale Sale after option exercise All abbreviations